Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
47.70 USD | +1.35% |
|
+4.66% | -5.44% |
May. 16 | Carlyle, SK Capital Partners And Bluebird Bio Provide Updated Tender Instructions | RE |
May. 16 | Carlyle Japan's Tomioka on Japan's PE Market | MT |
Highlights: The Carlyle Group Inc.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- The company's attractive earnings multiples are brought to light by a P/E ratio at 10.63 for the current year.
Weaknesses: The Carlyle Group Inc.
- The group shows a rather high level of debt in proportion to its EBITDA.
- The company's enterprise value to sales, at 4.55 times its current sales, is high.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- Over the past four months, analysts' average price target has been revised downwards significantly.
Ratings Chart: The Carlyle Group Inc.
Source: Surperformance
ESG chart: The Carlyle Group Inc.
Source: MSCI
Fundamentals | Valuation | Revisions of Fundamental Estimates | Capi.($) | ||
---|---|---|---|---|---|
17.11B | |||||
113B | |||||
112B | |||||
16.59B | |||||
- | 11.83B | ||||
11.76B | |||||
Average | 47.14B | ||||
Weighted average by Cap. |
Investor
Trader
ESG MSCI
BBB
Financials
Sales growth
EPS Growth
Profitability
Net margin
Financial Health
Valuation
P/E ratio
EV/REVENUE
EV/EBITDA
PBR
Yield
Revisions
1 year Revenue revision
4 months Revenue revision
1 months Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analysts' recommendations
4m Revision of opinion
Potential Price Target
4m Target Price Revision
12m Target Price Revision
Business Predictability
Earnings quality
Analyst Coverag
Divergence of analysts' recommendations
Divergence of Target Price
Divergence of analysts' opinions
ESG
ESG: Environment
ESG: Social
ESG: Governance
ESG: Controversy
ESG: Ethical controversies
ESG: Human rights controversies
ESG: Tax subsidies controversies
ESG: Sharia compliant
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- CG Stock
- Ratings The Carlyle Group Inc.
Select your edition
All financial news and data tailored to specific country editions